Epidermal growth factor receptors (EGFRs) are highly conserved members of the tyrosine kinase receptor superfamily found in metazoans and plants. In arthropods, EGFRs are vital for the proper development of embryos and of adult limbs, gonads, and eyes as well as affecting body size. In searching for genes involved in the growth and development of our model organism, the decapod crustacean (Macrobrachium rosenbergii), a comprehensive transcript library was established using next-generation sequencing. Using this library, the expression of several genes assigned to the signal transduction pathways mediated by EGFRs was observed, including a transcript encoding M. rosenbergii EGFR (Mr-EGFR), several potential ligands upstream to the receptor, and most of the putative downstream signal transducer genes. The deduced protein encoded by Mr-EGFR, representing the first such receptor reported thus far in crustaceans, shows sequence similarity to other arthropod EGFRs. The M. rosenbergii gene is expressed in most tested tissues. The role of Mr-EGFR was revealed by temporarily silencing the transcript through weekly injections of double-stranded Mr-EGFR RNA. Such treatment resulted in a significant reduction in growth and a delay in the appearance of a male secondary sexual characteristic, namely the appendix masculina. An additional function of Mr-EGFR was revealed with respect to eye development. Although the optic ganglion appeared to have retained its normal morphology, Mr-EGFR-silenced individuals developed abnormal eyes that presented irregular organization of the ommatidia, reflected by unorganized receptor cells occupying large areas of the dioptric portion and by a shortened crystalline tract layer. (Endocrinology 154: 3188 -3196, 2013) 
I
n earlier work, we identified and characterized an insulin-like hormone in the giant freshwater prawn, Macrobracium rosenbergii. This hormone, termed Mr-IAG, was found to determine sexual differentiation and to affect growth of the animal (1) . Recently it was shown that the insulin signaling pathway interconnects with the epidermal growth factor (EGF) signaling pathway (2) . Epidermal growth factor receptors (EGFRs) comprise an important and highly conserved receptor group that forms part of the EGF signal transduction pathway. Widely found in metazoans ranging from yeast to mammals, with detailed information having been primarily gathered from a few model organisms, EGFRs have yet to be identified in crustaceans.
EGFR is a transmembrane glycoprotein belonging to the tyrosine kinase receptor family. After activation by a variety of ligands, such as EGF and insulin (3), plasma membrane-localized monomeric tyrosine kinase receptors dimerize and autophosphorylate their cytoplasmic domains. This triggers the tyrosine kinase activity of the receptors that in turn stimulates a signal transduction cascade, leading to changes in cellular physiology and/or patterns of gene expression (4) .
Although EGFR functions similarly in vertebrates and invertebrates at the structural and cellular levels, with both inducing cell proliferation and differentiation, distinct phenotypic effects of receptor activity are seen in the 2 groups. EGFR plays crucial roles during vertebrate development, with mutations inducing defects in multiple organs, such as the brain, lung, skin, heart, and eye, and in many instances death (4) . Likewise, EGFR is also a major component controlling invertebrate development and has been extensively studied in model organisms, such as Drosophila melanogaster (5) , Caenorhabditis elegans (6) , and recently the cricket Gryllus bimaculatus (7) . Such studies have shown the EGFR to assume more than 30 distinct roles during invertebrate development, including those related to dorsoventral development, oogenesis, and spermatogenesis, eye development, and growth. In addition, research on invertebrate model organisms has shown that many physiological processes are influenced by the EGF pathway, including growth, development, reproduction, and aging. The EGFR-mediated cascade thus plays major roles in invertebrate life history regulation (8) and is thought to be important for the early development of M. rosenbergii, possibly intersecting with the Mr-IAG system that regulates sexual differentiation (9) . Indeed, the connection of a similar group of receptors, the insulin-like receptors, to masculine sexual differentiation was demonstrated in a vertebrate (10) .
To gain further insight into the role of the EGFR during invertebrate sexual development, a transcriptome library prepared from early developmental stages of the prawn M. rosenbergii recently established in our laboratory using next-generation sequencing techniques (11) was used to mine for EGFR-related transcripts. Among the EGFR-related transcripts identified, several were found upstream of the receptor, encoding potential ligands, whereas genes involved in the cellular signal transduction cascade of the EGFR pathway were identified downstream of the receptor. To elucidate the function of EGFR, the application of long double-stranded (ds) RNA was performed similarly to our previous work in the prawn (1, 12) . Although, the mechanism by which the long dsRNA is internalized into crustacean cells is not fully understood, it is hypostasized that the dsRNA travels via the circulating hemolymph to distant tissues (13, 14) . Our findings on the function of M. rosenbergii EGFR represent, to the best of our knowledge, the first such report from any crustacean. Upon long-term silencing of M. rosenbergii EGFR expression from the early post-larvae (PL) stage, a significant reduction in growth, delayed development of an external sexual characteristic, and abnormalities in eye development were observed.
Materials and Methods

Animals
M rosenbergii PL 16 (postlarvae, 16 d from metamorphosis) males were produced from a 'neo-female' animal and maintained at Ben-Gurion University of the Negev, as previously described (12) . These individuals were used to study the effects of dsMr-EGFR treatment. Mature male and female individuals, progeny of normal females, were used for tissue specificity assessment.
Bioinformatics analyses
Genes encoding putative components of a generalized diagram of the EGF signal transduction cascade were excavated, based on the report by Borisov et al (2) , as were potential EGFR ligands, including Mr-IAG (1) and 4 D. melanogaster EGFR ligands (5) . A key word-based search of our transcript library (11) yielded several sequences, which then served as queries in the BLAST searches designed to reveal the similarity between our hypothetical sequences and those homologues found in other organisms.
To obtain the deduced protein sequence, full length Mr-EGFR cDNA was computationally translated using the ExPASy Proteomics Server (http://web.expasy.org/translate/),and the most likely frame was selected (ie, the first 5Ј to 3Ј frame). Conserved domains were identified in the putative Mr-EGFR protein using Simple Modular Architecture Research Tool (SMART) (15) . Using ClustalW (16) , multiple sequence alignment of the predicted Mr-EGFR sequence was performed with 2 representative arthropod members of the EGFR family, namely from D. melanogaster (GenBank accession number AAM70919) and Apis mellifera (UniprotKB accession number P0cCY46).
Spatial expression pattern of Mr-EGFR
The spatial expression pattern of Mr-EFGR was examined by RT-PCR. Total RNA was isolated from the male testis, hepatopancreas, androgenic gland, thoracic-ganglia, sperm duct, heart, and tail muscle from 3 mature males. Two of the males were in the intermolt stage and one at postmolt. RNA was also extracted from the ovary, hepatopancreas, thoracic-ganglia, heart, and tail muscle of 3 mature females, all at the intermolt stage, as previously described (12) . All tissue sampling was done after the animals were anesthetized on ice for 10 minutes. First-strand cDNA was synthesized by reverse transcription using the Verso cDNA kit (Thermo Fisher Scientific, Epsom, Surrey) with 1 g of total RNA. Specific Mr-EGFR forward (Mr-EGFR-1F; nucleotides 88 -111, 5Ј-GCAAGGACAAAGGGAAAATATGC-3Ј) and reverse (Mr-EGFR-R; nucleotides 576 -599, 5Ј-CAGGATTTG-GAGCACTGACAAGT-3Ј) primers were used for PCR amplification, as previously described (12) , except that 37 cycles and an annealing temperature of 60°C was used here. Mr-actin, serving as a positive control, was amplified as previously described (1) . PCR products were separated on a 1.2% agarose gel, visualized by ethidium bromide staining, and photographed under UV illumination by a gel image documentation system (Bio Imaging system; Chemi Genius, Syngene, Cambridge, United Kingdom).
Preparation of dsRNA
Two PCR products were prepared using a T7 promoter anchor (T7P; 5Ј-TAATACGACTCACTATAGGG-3Ј) attached to one primer for each product. The primers used for generating the template for sense-strand RNA synthesis were (5Ј-T7P-GAAA-GATAGTGGTGCCTGCGTTA-3Ј) as forward primer and (5Ј-CTTTTCCCCAGCAACCTTCATTA-3Ј) as reverse primer. Primers used for generating the template for antisense strand RNA synthesis were 5Ј-GAAAGATAGTGGTGCCTGCG-TTA-3Ј as forward primer and 5Ј-T7P-CTTTTCCCCAG-CAACCTTCATTA-3Ј. PCR amplicons were separated by electrophoresis on a 1.2% agarose gel, visualized with ethidium bromide and UV light, excised from the gel, and purified with a HiYield Gel/PCR DNA fragments extraction kit (RBC Bioscience, New Taipei City, Taiwan). dsRNA of the Mr-EGFR open reading frame (650 nucleotides from positions 918 to 1567 was prepared using a TranscriptAid T7 high yield transcription kit (Fermentas UAB, Vilnius, Lithuania), according to the manufacturer's instructions. The 2 strands were hybridized by heating to 70°C for 15 minutes and to 65°C for 15 minutes, followed by incubation at room temperature for 30 minutes. RNA was quantified and diluted to 1 g/L and quality was assessed on an agarose gel. The dsRNA was maintained at Ϫ80°C until used.
In vivo Mr-EGFR silencing
Ninety-five PL 16 male individuals, progeny of a 'neo-female' (17), were collected and divided into 2 groups. Each individual was injected on a weekly basis. Seventy-one individuals were injected with dsMr-EGFR (5 g/g body weight). Twenty-four individuals were injected with Remebee (RB), a dsRNA formulated to silence Israeli acute paralysis virus affecting bees (18) , supplemented by Beeologics (Rehovot, Israel; 5 g/g body weight).
Body weight was monitored weekly up to the 13th week. One day after the 13th injection, 6 individuals from each treatment were taken for Mr-EGFR transcript level analysis by real-time RT-PCR, whereas the remaining individuals were kept under the weekly injection regimen and the development of the appendix masculina (AM) was monitored until the point that all control individuals have developed the AM (week 25). From week 22 to week 25, remaining individuals of the treatment group were monitored for molt events weekly, and compared to control animals at the same age, size, and conditions, in order to study the molting rate/growth interrelationship.
Relative quantitation of Mr-EGFR expression levels
RNA was extracted from the testes of silenced individuals after 13 injections of dsMr-EGFR and from control individuals injected with Remebee (Beeologics). Total RNA was isolated with the EZ-RNA total RNA isolation kit (Biological Industries, Beit Haemek, Israel), according to the manufacturer's instructions. First-strand cDNA was synthesized using the Verso cDNA kit (Thermo Fisher Scientific) with 1 g of total RNA. Relative quantification of Mr-EGFR transcript levels was achieved using the Mr-EGFR quantitative PCR forward (5Ј-GAAA-GAAAATACGCTCACCTTG-3Ј) and Mr-EGFR quantitative PCR reverse (5Ј-AGTCACCTCTTGGACGTTGC-3Ј) primers together with the FastStart Universal probe master (Rox; Roche Diagnostics, Penzberg, Germany) and Universal ProbeLibrary Probe 50 (Roche) kits. Mr-18S (GenBank accession number GQ131934), serving as a normalizing gene, was also quantified by means of real-time RT-PCR using primers quantitative Mr-18S forward (5Ј-CCCTAAACGATGCTGACTAGC-3Ј) and quantitative Mr-18S reverse (5Ј-TACCCCCGGAACT-CAAAGA-3Ј) with the above-mentioned mix and the Universal ProbeLibrary Probe 152 kit (Roche). Reactions were performed using the ABI Prism 7300 sequence detection system (Applied Biosystems, Foster City, California).
Eye histology and scanning electron microscopy (SEM)
Eyes from one individual of each group were removed at the base of the eye stalk. Left eye samples were fixed in modified Carnoy's II for 48 hours at 4°C and dehydrated gradually through a series of increasing alcohol concentrations. The tissues were cleared and embedded in Paraplast (Kendall, Mansfield, Massachusetts), according to conventional procedures. Sections (5 m thick) were mounted onto silane-coated slides (MenzelGläser, Braunschweig, Germany), stained with hematoxylin and eosin, and observed under a light microscope. Right eye stalks were prepared as previously described by Bitan et al (19) for SEM.
Statistical analyses
The effects of dsRNA injection on relative transcript levels, as revealed by the real-time RT-PCR, were statistically analyzed by the nonparametric Mann-Whitney U test using Statistica 6.1 (20) was used. The model is expressed by the equation (t; z) ϭ 0 (t)exp (␤izi), where (t,z) represents AM development and 0 (t) corresponds to the baseline AM development rate that can change over time (t). The regression coefficient to be estimated, ␤i, represents the independent effect of dsRNA injection on AM development. Exp ␤ represent the expected change in AM developmental rate after the treatment. Analysis was performed using S-PLUS 2000 software (Mathsoft, Needham, Massachusetts).
Results
Identification of putative components of the Mr-EGF signaling cascade
In our M. rosenbergii postembryonic transcriptomic library (11), transcripts putatively involved in the EGF signaling cascades were found (Figure 1 ), including EGFR, Mr-IAG, and 4 other potential EGFR ligands. Three of the ligands (Spitz, Gurken, and Keren) showed high similarity to the sequence of one contig (identical domain structures), whereas a fourth ligand, Argos, showed high similarity to another contig (Table 1 ). All downstream EGF cascade genes listed by Borisov et al (2) were also found in our library (see Supplemental  Table 1 , published on The Endocrine Society's Journals Online web site at http://endo.endojournals.org).
Sequence of the Mr-EGFR transcript and the deduced protein
Efforts focused on that transcript possessing high similarity (as high as 60%) to known EGFRs in the GenBank database and thus termed M rosenbergii epidermal growth factor receptor (Mr-EGFR). Mr-EGFR (accession number NCBI SRA STUDY PRJNA174197) is 6864 nucleotides long, with a predicted open reading frame encoding a 1461-amino acid (aa) translation product, a 138-bp 5Ј-untranslated region and a 2340 bp 3Ј-untranslated region ending with a poly A tail (Supplemental Figure 1) . (Figure 2 ). Multiple sequence alignment of the 2 ligand-binding domains of Mr-EGFR and the D melangostar and A mellifera EGFRs computed by the ClustalW algorithm revealed a high degree of similarity ( Figure 3A) . SMART representation of the 3 full sequences demonstrated the highly similar domain patterns of Mr-EGFR and D melanogaster EGFR, with lesser similarity between Mr-EGFR and A mellifera EGFR being noted ( Figure 3B ). The ex- 
The spatial expression pattern of Mr-EGFR
RT-PCR showed that in adult M. rosenbergii, the Mr-EGFR transcript is expressed in the gonads and thoracic ganglia of both male and female animals. Amplification was also observed in the heart, hepatopancreas, and tail muscles of both males and females and also in the male sperm duct (represented in Figure 4 by a male and female in the intermolt stage. All trials showed a similar expression pattern). No expression was detected in the androgenic gland.
Mr-EGFR silencing and effects on growth, molt, and secondary sexual characteristics
Real-time RT-PCR performed using RNA extracted from the testes of treated males showed significant reduction (ϳ98%) in Mr-EGFR transcript levels, as compared with the control group (Mann-Whitney U test, P Ͻ .001; Figure 5 ). Mr-EGFR silencing resulted in a significant inhibition of accumulated body weight, as compared with the control group, from the sixth injection at PL 50 (Mann-Whitney U test, P Ͻ 0.001; Figure 6A ). The average body weight of control group individuals was 870.4 Ϯ 76.4 mg, whereas the average body weight of injected individuals was 319.2 Ϯ 28.2 mg on the 13th week of the experiment. Molting frequency was unaffected by the silencing ( 2 test, t ϭ 0.04, df ϭ 3, P ϭ .985) ( Figure 6B ). The percentage of molting events per week was similar in both the control and silenced groups (76.3% and 76.6%, respectively). The development of AM, a male-specific secondary sexual characteristic, was also delayed in the Mr-EGFR-silenced group. In the control group, the AM appeared as early as PL 57 , whereas in the Mr-EGFR-silenced group, the first AM appeared only at PL 84 . This delay became significant (Cox proportional hazards regression model, P Ͻ .05) by PL 99 , when compared with the control group. By PL 106 , all individuals in the control group had developed the AM, whereas in the Mr-EGFR-silenced group, Figure 2 . The deduced amino acid sequence Mr-EGFR. Beginning at the N terminus, one finds a signal peptide (bold, double underlined), 2 ligand-binding domains (bold and italicized, gray background), 7 interspersed Furin-like domains (bold, dashed underline), a transmembrane domain (bold, italicized), a tyrosine kinase domain (gray boxes), and 2 low-complexity domains (bold and italicized, dashed-dot underline).
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only 47.6% of the animals had developed the AM by this point ( Figure 6C ).
Effects of Mr-EGFR silencing on eye development
In Mr-EGFR-silenced prawns, the optic portion of the eye was about half the size of a normal eye of an equally sized control individual (Figure 7 , middle panels). Histological sections show that the cornea, crystalline cones, and crystalline tracts are present in silenced individuals (Figure 7 , left bottom panel), although they were reduced to about half the size of the normal tracts in the intact eye ( Figure 7, left top panel) . In addition, the rhabdoms seem denser and thicker and appear to have much more surrounding pigmentation, as compared with a normal eye. The 3 ganglia regions in the eye stalk, ie, the medulla terminalis, medulla interna, and medulla externa, appear to be normal in the eyes of silenced individuals ( Figure 7 , left panels). The 3-dimensional surface of the eye was examined by SEM, which revealed that the shape of the facets on the surface of the optic portion was deformed. Whereas in the normal eye the facets have a rectangular shape, the eye facets of Mr-EGFR-silenced animals exhibited irregular shapes (Figure 7 , right panels).
Discussion
One of the transcripts found in the transcriptomic library of juvenile M. rosenbergii prawns (11), termed Mr-EGFR, represents the first gene of the EGFR family to be found in crustaceans. In the same library, we also detected transcripts representing most of the genes involved in the general EGF signaling cascade, as proposed by Borisov et al (2) (see Figure 1) , including the gene encoding ERK, the MAPK. ERK is the ultimate enzyme in the cascade that targets many proteins whose activation eventually leads to cell proliferation and differentiation (21). Borisov et al (2) suggested that many of these genes are shared with the insulin-signaling cascade.
The insulin-like androgenic gland hormone discovered in M. rosenbergii (1) was found to control sexual differentiation and to sustain male sexual characteristics and was suggested to be a driving force behind bimodal growth in this species, in which males grow faster and reach higher weights than do females (1, 9) . It has been known for several years that insulin can be mitogenic (22) , whereas EGF can evoke metabolic responses (23) . Both share many downstream components in their networks and were found to regulate each other's pathway of signal transduction (2). In our library of juvenile M. rosenbergii transcripts, we found many components of the insulin and EGF signal transduction networks suggested by Borisov et al (2) as possibly interacting. However, from the results presented here, it seems that in the prawn, interactions between the insulin (Mr-IAG) and EGF cascades are likely not extensive because Mr-EGFR is expressed in both adult males and females and in all tissues but the androgenic gland, whereas Mr-IAG is produced and expressed exclusively in males and in the androgenic gland (1). Emlen et al (24) suggested that the insulin and EGF pathways are involved with the development and evolution of secondary sexual characteristic in beetles. Similarly, our study demonstrated delayed development of the AM in the Mr-EGFR-silenced group. However, this seems to be related to growth rather than reproduction because no shifting of reproductive system development, as noted upon silencing of Mr-IAG, was observed (12, 25) . Without further study, the involvement of EGFR in sexual differentiation cannot be completely ruled out. Indeed, the role of EGFR in M rosenbergii seems to be mostly related to the control of growth because silencing of the gene slowed mass accumulation in young males rather than frequency of molt events. These results agree with the findings of studies demonstrating the involvement of EGFR in body size regulation in arthropods, such as D. melanogaster, A. mellifera, and the cricket Gryllus bimaculatus (5, 7, 26) . With respect to possible Mr-EGFR ligands, Mr-IAG, mentioned above, is a member of the insulin-like family and has been proven to be a growth regulator in M. rosenbergii (1). This is further implied through the suggested cross talk between the 2 cascades (2) and reports on the A, Body weight of Mr-EGFR-dsRNA-injected (E) and dsRB-RNA injected (F) groups. Statistically significant differences (asterisks) were observed from the first measurement onward (Mann-Whitney U test, P Ͻ .001). Weekly injections started 16 days after metamorphosis. B, A 4-week comparison of individuals molted (percentage) per week in silenced vs control prawns was conducted ( 2 test, P ϭ .829). C, Cumulative appearance of the appendix masculina as a percentage of the population in Mr-EGFR-dsRNA-injected (E) and dsRB-RNA-injected (F) groups. *, Statistically significant differences (Cox proportional hazards test, P Ͻ .05).
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Sharabi et al Prawn EGFR Function and Putative Cascade Endocrinology, September 2013, 154(9):3188 -3196 possible effects of insulin on EGFR (27, 28) . However, the above differences in the mode of action and expression suggest that Mr-IAG is probably not a ligand of Mr-EGFR. Other than Mr-IAG, our next-generation sequencing library includes transcripts similar to 4 growth and development regulator ligands known to interact with D. melanogaster EGFR, as described by Shilo (5) . Three of these ligands (Spitz, Keren, and Gurken) were mapped to the same M rosenbergii transcript from our library because all three are TGF-␣ homologues. The fourth ligand identified (Argos) was similar to a different transcript, in agreement with it being a D. melanogaster EGFR inhibitor and it following a different trafficking and processing pathway from the other 3 ligands (5). We did not identify a fifth ligand mentioned by Shilo (5), termed Vein, in our library. Also, the functions of the above-mentioned ligands in the context of the EGF cascade need to be further elaborated. In arthropods, EGFR is known to play an important role in the recruitment of almost all cell types involved in the development of the ommatidium (29) . Moreover, EGFR inhibition in Drosophila prevented differentiation of cone and pigment cells, as well as receptor cells, in the eye (30) . Similarly, our study in crustaceans demonstrated a major effect of Mr-EGFR silencing related to eye morphology. Decapods from the family Palaemonidae have what is known as superposition eyes, which are characterized by certain anatomical features, the most notable of which are the square shape of the facets, unlike the hexagonal shape in aposition eyes (31) , and the fact that the rhabdoms are separated from the crystalline cones by considerable distances (31) (32) (33) . These distances were found to be significantly shorter in the eyes of Mr-EGFR-silenced M. rosenbergii.
Most of the research on the involvement of EGFR in regard to eye development in arthropods has been performed on Drosophila, which possess aposition eyes much like prawn larva but unlike superposition eyes of postlarval and adult prawns. Aposition eyes do not contain crystalline tract or a clear zone, and the crystalline cones are in contact with the rhabdoms (34, 35) . Thus, studies on the role of EGFR in prawn eye development could not be readily compared with studies on their fly counterparts, including the major effects seen in our study on the arrangement of the rhabdoms and their shape as well as on the proliferation of pigment cells in the prawn eye. Facets of prawn larvae, which are hexagonal, transform into the adult square form during metamorphosis (33, 36) . Normally, crustacean eyes grow by adding new ommatidias each successive molt (37) . It is possible that during the period of the injections and the silencing of Mr-EGFR, the process of forming and adding new ommatidias was negatively affected; having said that, we do not know whether there was any cell loss.
To the best of our knowledge, this study represents the first report of an EGFR, its upstream ligands, and its downstream putative signaling cascade in Decapoda. Our silencing of this gene revealed 3 morphological effects (eye development, delayed AM development, and total body size), whereas in other arthropods, such as A. mellifera and D. melanogaster, many more phenotypes were affected (5, 26) . As in insects, EGFR might also play an important role in early developmental stages in crustaceans. Because our experiment was conducted at later developmental stages, it is likely that Mr-EGFR silencing in crustacean larvae and during the metamorphosis will elucidate additional roles.
ies. We also thank Beeologics for their donation of Remebee dsRNA.
